Published by Michele Maatouk on 30th August 2022
(Sharecast News) - AstraZeneca said on Tuesday that its Evusheld long-acting antibody combination has been approved in Japan for the prevention and treatment of Covid-19.
URL: http://www.digitallook.com/dl/news/story/32925344/...